These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 25586554

  • 21. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET, Scott RA, Cade D, Connor AL, Wilding IR.
    Pharm Res; 2004 May 31; 21(5):793-8. PubMed ID: 15180336
    [Abstract] [Full Text] [Related]

  • 23. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA, Stach PE.
    Drug Dev Ind Pharm; 1998 Jun 31; 24(6):493-500. PubMed ID: 9876614
    [Abstract] [Full Text] [Related]

  • 24. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M, Bodmeier R.
    Eur J Pharm Biopharm; 2006 Feb 31; 62(2):178-84. PubMed ID: 16260126
    [Abstract] [Full Text] [Related]

  • 25. [A review on liquid-filled hard gelatin capsules].
    Ma JH, Yang M, Zeng M, Chen XM, Lan J.
    Zhongguo Zhong Yao Za Zhi; 2008 Mar 31; 33(5):602-5. PubMed ID: 18536390
    [Abstract] [Full Text] [Related]

  • 26. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
    Birchall JC, Jones BE, Morrissey A, Jones BE.
    Drug Dev Ind Pharm; 2008 Aug 31; 34(8):870-6. PubMed ID: 18686093
    [Abstract] [Full Text] [Related]

  • 27. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N, Hennia I, Ecenarro S, Amighi K.
    Int J Pharm; 2018 Dec 20; 553(1-2):47-56. PubMed ID: 30321640
    [Abstract] [Full Text] [Related]

  • 28. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 Dec 20; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 29. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C, Khela MK, Evans DF, Jones BE, Nagata S, Basit AW.
    Eur J Pharm Sci; 2007 Mar 20; 30(3-4):251-5. PubMed ID: 17188473
    [Abstract] [Full Text] [Related]

  • 30. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD, Carroll SC, Colgan ST, Yeoh T, MacDonald BC, Johnson GM, Space JS.
    J Pharm Sci; 2018 Dec 20; 107(12):3080-3088. PubMed ID: 30145210
    [Abstract] [Full Text] [Related]

  • 31. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE, Basit AW, Tuleu C.
    Int J Pharm; 2012 Mar 15; 424(1-2):40-3. PubMed ID: 22214655
    [Abstract] [Full Text] [Related]

  • 32. Multi-methodological investigation of the variability of the microstructure of HPMC hard capsules.
    Faulhammer E, Kovalcik A, Wahl V, Markl D, Stelzer F, Lawrence S, Khinast JG, Paudel A.
    Int J Pharm; 2016 Sep 25; 511(2):840-54. PubMed ID: 27497996
    [Abstract] [Full Text] [Related]

  • 33. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W, Liu P, Johnson BA, Hausberger A, Quan E, Vendola T, Vatsaraj N, Foulds G, Vincent J, Chandra R.
    Pharm Res; 2011 Jul 25; 28(7):1531-9. PubMed ID: 21331473
    [Abstract] [Full Text] [Related]

  • 34. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
    Zhao F, Malayev V, Rao V, Hussain M.
    Pharm Res; 2004 Jan 25; 21(1):144-8. PubMed ID: 14984269
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU, Okor RS.
    Acta Pol Pharm; 2007 Jan 25; 64(1):73-9. PubMed ID: 17665854
    [Abstract] [Full Text] [Related]

  • 36. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E, Yépez-Mulia L, Jesús Hernández-Abad V, Jung Cook H.
    Pharm Dev Technol; 2015 May 25; 20(3):306-13. PubMed ID: 24417644
    [Abstract] [Full Text] [Related]

  • 37. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
    Pennings FH, Kwee BL, Vromans H.
    Drug Dev Ind Pharm; 2006 Jan 25; 32(1):33-7. PubMed ID: 16455602
    [Abstract] [Full Text] [Related]

  • 38. Influence of Polymer Type on the Physical Properties and Release Profile of Papaverine Hydrochloride From Hard Gelatin Capsules.
    Polski A, Iwaniak K, Kasperek R, Modrzewska J, Sobótka-Polska K, Sławińska K, Poleszak E.
    Polim Med; 2015 Jan 25; 45(2):51-5. PubMed ID: 26994886
    [Abstract] [Full Text] [Related]

  • 39. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G, Csontos B, Sovány T, Regdon G, Bényei A, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Nguyen TLP, Vecsernyés M, Fenyvesi F.
    AAPS PharmSciTech; 2018 Oct 25; 19(7):3165-3176. PubMed ID: 30136176
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.